These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9249242)
1. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study. Waldeck K; Lindberg BF; Persson K; Andersson KE Br J Pharmacol; 1997 Jul; 121(6):1081-6. PubMed ID: 9249242 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle. Lindberg BF; Nilsson LG; Hedlund H; Stahl M; Andersson KE Am J Physiol; 1994 Jun; 266(6 Pt 2):R1861-7. PubMed ID: 8024040 [TBL] [Abstract][Full Text] [Related]
3. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system. Nishimura H; Buikema H; Baltatu O; Ganten D; Urata H Am J Physiol; 1998 Oct; 275(4):H1307-12. PubMed ID: 9746480 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Petrie MC; Padmanabhan N; McDonald JE; Hillier C; Connell JM; McMurray JJ J Am Coll Cardiol; 2001 Mar; 37(4):1056-61. PubMed ID: 11263608 [TBL] [Abstract][Full Text] [Related]
5. Alternative pathways of angiotensin II production in the human saphenous vein. Borland JA; Chester AH; Morrison KA; Yacoub MH Br J Pharmacol; 1998 Oct; 125(3):423-8. PubMed ID: 9806322 [TBL] [Abstract][Full Text] [Related]
6. Modulation of angiotensin-converting enzyme by nitric oxide. Ackermann A; Fernández-Alfonso MS; Sánchez de Rojas R; Ortega T; Paul M; González C Br J Pharmacol; 1998 May; 124(2):291-8. PubMed ID: 9641545 [TBL] [Abstract][Full Text] [Related]
7. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats. Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510 [TBL] [Abstract][Full Text] [Related]
8. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases. Liao Y; Husain A Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213 [TBL] [Abstract][Full Text] [Related]
9. Dual pathway for angiotensin II formation in human internal mammary arteries. Voors AA; Pinto YM; Buikema H; Urata H; Oosterga M; Rooks G; Grandjean JG; Ganten D; van Gilst WH Br J Pharmacol; 1998 Nov; 125(5):1028-32. PubMed ID: 9846641 [TBL] [Abstract][Full Text] [Related]
10. The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats. Jin D; Takai S; Yamada M; Sakaguchi M; Miyazaki M Jpn J Pharmacol; 2000 Dec; 84(4):449-54. PubMed ID: 11202618 [TBL] [Abstract][Full Text] [Related]
11. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries. Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696 [TBL] [Abstract][Full Text] [Related]
12. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum. Iwamoto Y; Song K; Takai S; Yamada M; Jin D; Sakaguchi M; Ueda H; Katsuoka Y; Miyazaki M J Pharmacol Exp Ther; 2001 Jul; 298(1):43-8. PubMed ID: 11408523 [TBL] [Abstract][Full Text] [Related]
13. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase. Urata H; Ganten D Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772 [TBL] [Abstract][Full Text] [Related]
14. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart. Katugampola SD; Davenport AP Clin Sci (Lond); 2002 Jan; 102(1):15-21. PubMed ID: 11749656 [TBL] [Abstract][Full Text] [Related]
15. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway? Husain A; Li M; Graham RM Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473 [No Abstract] [Full Text] [Related]
16. Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype. Hu WY; Fukuda N; Ikeda Y; Suzuki R; Tahira Y; Takagi H; Matsumoto K; Kanmatsuse K; Mugishima H J Cell Physiol; 2003 Aug; 196(2):284-92. PubMed ID: 12811821 [TBL] [Abstract][Full Text] [Related]
17. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. Li M; Liu K; Michalicek J; Angus JA; Hunt JE; Dell'Italia LJ; Feneley MP; Graham RM; Husain A J Clin Invest; 2004 Jul; 114(1):112-20. PubMed ID: 15232618 [TBL] [Abstract][Full Text] [Related]
18. Cardiac and vascular actions of decapeptide angiotensin analogs. Baker KM; Khosla MC J Pharmacol Exp Ther; 1986 Dec; 239(3):790-6. PubMed ID: 3025418 [TBL] [Abstract][Full Text] [Related]
19. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells. He S; Gaça MD; McEuen AR; Walls AF J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension. Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]